Baillie Gifford trim Denali Therapeutics Inc.
Baillie Gifford trim $251.0M of disclosed value in Denali Therapeutics Inc..
Signal
Investor Move
Action
Trim
Capital
$251.0M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.